Clinical Trials Browser

Phase 3 × Megestrol Acetate × 30 days × Clear all

NCT04939090 2026-03-04

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Phase 3 Recruiting

Other hematologic neoplasm

Anorexia, Hematologic Neoplasms